This site is intended for healthcare professionals
  • Home
  • /
  • Journals
  • /
  • Uncategorised Disease
  • /
  • Patient-reported outcomes and considerations in th...
Journal

Patient-reported outcomes and considerations in the management of COPD: focus on aclidinium.

Read time: 1 mins
Published:25th Mar 2020
Author: Lopez-Campos JL, Calero C, Lopez-Ramirez C, Asensio-Cruz MI, M�rquez-Mart�n E, Ortega-Ruiz F.
Ref.:Patient Prefer Adherence. 2015 Jan 17;9:95-104. eCollection 2015.
DOI:10.2147/PPA.S55009.

Background: This study evaluated the effects of aclidinium bromide, a long-acting muscarinic antagonist indicated for maintenance treatment of chronic obstructive pulmonary disease (COPD), on exercise endurance, dyspnea, lung hyperinflation, and physical activity.
Conclusions: These results suggest that aclidinium significantly improves exercise endurance, exertional dyspnea, hyperinflation, and physical activity in patients with COPD.

 

Read abstract on library site